Improve seated motor cognitive function
- Trial ID
- NCT06730074
- Official Title
- A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease
- Goal
- Improve seated motor cognitive function
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Adi Negev-Nahalat Eran
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease, Idiopathic
- Interventions
- Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)
Plain-Language Summary
The goal is to see if a seated, robot-assisted, gamified exercise program with music can improve motor control and cognitive-motor skills that often worsen in Parkinson's, like hand coordination, timing, and dual-tasking. Participants will use robotic devices that guide and resist upper-limb movements while music and game feedback provide rhythm and attention cues, with precise sensors to retrain movement patterns and keep people motivated; it is a non-drug rehabilitation tool meant to complement medications like levodopa rather than replace them. The study is looking for Hebrew-speaking adults aged 50 to 75 with idiopathic Parkinson's at Hoehn and Yahr stage 3 or below, a MoCA score of 23 or higher, and no major upper-limb orthopedic issues or uncorrected vision or hearing problems.
Locations
- Adi Negev, Ofakim, South, Israel
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD). The goal is to see if a seated, robot-assisted, gamified exercise program with music can improve motor control and cognitive-motor skills that often worsen in Parkinson's, like hand coordination, timing, and dual-tasking. Participants will use robotic devices that guide and resist upper-limb movements while music and game feedback provide rhythm and attention cues, with precise sensors to retrain movement patterns and keep people motivated; it is a non-drug rehabilitation tool meant to complement medications like levodopa rather than replace them. The study is looking for Hebrew-speaking adults aged 50 to 75 with idiopathic Parkinson's at Hoehn and Yahr stage 3 or below, a MoCA score of 23 or higher, and no major upper-limb orthopedic issues or uncorrected vision or hearing problems.
- Who can participate?
- Participants must be between 50 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.